People with atrial fibrillation (irregular heartbeat) face an increased risk of dementia, a new study warns; but common drugs may keep that risk in check. Read & Research Alzheimer’s More

Be the first to comment
            

The Alzheimer’s Association convened a multidisciplinary workgroup to develop appropriate use criteria to guide the safe and optimal use of the lumbar puncture procedure and cerebrospinal fluid (CSF) testing for Alzheimer’s disease pathology detection in the diagnostic process. Read & Research Alzheimer’s More

Be the first to comment
            

We explore here a novel model for amyloidogenesis in Alzheimer’s disease (AD). This new perspective on AD amyloidosis seeks to provide a rational framework for incorporating recent and seemingly independent findings on the antimicrobial role of β-amyloid and emerging experimental, genetic, and epidemiological data, suggesting innate immune-mediated inflammation propagates AD Read & Research Alzheimer’s More

Be the first to comment
            

Dementia is an umbrella term that describes symptoms affecting memory and cognitive function. Alzheimer’s disease is a specific, and the most common, type of dementia. The conditions overlap in terms of symptoms, but Alzheimer’s has different and specific treatments as well as unique symptoms. Learn more here. Read & Research Alzheimer’s More

Be the first to comment
            

Predicting who will develop dementia is difficult. Researchers are testing various biomarkers, but a recent study asks whether apathy might provide a clue. Read & Research Alzheimer’s More

Be the first to comment
            

Neurodegenerative diseases encompass a range of diagnoses, such as Alzheimer’s disease and Parkinson’s disease. Despite decades of advancements in understanding the neurobiology of individual diseases, this class has few disease-modifying therapeutics and a paucity of biomarkers for diagnosis or progression. However, tau protein aggregation has emerged as a potential unifying Read & Research Alzheimer’s More

Be the first to comment
            

Little is known about factors affecting motivation and satisfaction of participants in dementia prevention trials. Read & Research Alzheimer’s More

Be the first to comment
            

Contents"> Contents

Posted October 1, 2018 By

Read & Research Alzheimer’s More

Be the first to comment
            

At an estimated $277 billion in 2018 dollars, Alzheimer’s disease (AD) is the most expensive disease in the United States. By 2050, the cost could be as high as $1.1 trillion. AD is the sixth leading cause of death in the United States. AD-related deaths from 2000 to 2015 increased Read & Research Alzheimer’s More

Be the first to comment
            

New research supports the idea that physical activity delays cognitive decline and other changes in the rare early-onset form of Alzheimer’s disease. Read & Research Alzheimer’s More

Be the first to comment
            

Now that scientists agree that oligomer protein deposits cause Alzheimer’s, an international team has detailed a plan for developing drugs to target them. Read & Research Alzheimer’s More

Be the first to comment
            

Little is known about effects of physical activity (PA) in genetically driven early-onset autosomal dominant Alzheimer’s disease (AD). Read & Research Alzheimer’s More

Be the first to comment
            

The first study to ever predict Alzheimer’s prevalence by race and ethnicity estimates that the United States burden of the disease will double by 2060. Read & Research Alzheimer’s More

Be the first to comment
            

A number of risk factors are known for dementia; these include hypertension, a sedentary lifestyle, obesity, and smoking. A new study may add another. Read & Research Alzheimer’s More

Be the first to comment
            

We tested the hypothesis that low plasma complement C3 is observationally and genetically associated with high risk of Alzheimer’s disease. Read & Research Alzheimer’s More

Be the first to comment
            

In 2016, the UC Davis Latino Aging Research Resource Center and UC Davis Alzheimer’s Disease Center brought together experts from across the country to consolidate current knowledge and identify future directions in aging and diversity research. This report disseminates the research priorities that emerged from this conference, building on an Read & Research Alzheimer’s More

Be the first to comment
            

We sought to examine the genetic overlap between vascular pathologies and Alzheimer’s disease (AD) dementia, and the potential mediating role of vascular pathologies between AD-related genetic variants and late-life cognition. Read & Research Alzheimer’s More

Be the first to comment
            

Several concepts, which in the aggregate get might be used to account for “resilience” against age- and disease-related changes, have been the subject of much research. These include brain reserve, cognitive reserve, and brain maintenance. However, different investigators have use these terms in different ways, and there has never been Read & Research Alzheimer’s More

Be the first to comment
            

The objective of this study was to examine the prevalence of the coexistence of parkinsonism in patients with mild cognitive impairment (MCI) or mild Alzheimer’s disease (AD). Read & Research Alzheimer’s More

Be the first to comment
            

According to a new study, there may be a link between daytime sleepiness and an increased risk of developing Alzheimer’s later in life. Read & Research Alzheimer’s More

Be the first to comment
            

A new study investigating seasonal variation in cognitive ability concludes that more people reach the threshold for a dementia diagnosis in winter. Read & Research Alzheimer’s More

Be the first to comment
            

The trends in prevalence and incidence of Alzheimer’s disease (AD) dementia remain uncertain. Read & Research Alzheimer’s More

Be the first to comment
            

Tangles of tau protein are a hallmark of Alzheimer’s disease. Now, scientists have uncovered a new mechanism through which tau disrupts brain cells. Read & Research Alzheimer’s More

Be the first to comment
            

A new study provides 10-year estimates for dementia risk, focusing on age, sex, and genetic predisposition. This may lead to early preventive initiatives. Read & Research Alzheimer’s More

Be the first to comment
            

An existing drug used to treat liver disease could also be effective in Alzheimer’s disease, researchers find. Better Alzheimer’s therapy is much needed. Read & Research Alzheimer’s More

Be the first to comment
            

In the largest analysis of its type to date, researchers conclude that stroke significantly increases the risk of developing dementia in older age. Read & Research Alzheimer’s More

Be the first to comment
            

Stroke is an established risk factor for all-cause dementia, though meta-analyses are needed to quantify this risk. Read & Research Alzheimer’s More

Be the first to comment
            

Using an innovative approach, scientists move one step closer to a treatment for Alzheimer’s. Learning how to tame the brain’s immune system is vital. Read & Research Alzheimer’s More

Be the first to comment
            

A study of blood flow in 128 brain regions in 30,000 people aged 0–105 years has identified behaviors and disorders that speed up brain aging. Read & Research Alzheimer’s More

Be the first to comment
            

A new study links Alzheimer’s toxic waste buildup in the brain to the functioning of the ‘cellular waste removal’ system: the endolysosomal system. Read & Research Alzheimer’s More

Be the first to comment